Overview

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Status:
Not yet recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to investigate the efficacy and safety of temozolomide in SDH deficiency GIST patients.
Phase:
Phase 2
Details
Lead Sponsor:
Asan Medical Center
Treatments:
Temozolomide